Chemoinformaics analysis of Bicyclo[2.2.1]heptan-1-ol
Molecular Weight | 112.172 | nRot | 0 |
Heavy Atom Molecular Weight | 100.076 | nRig | 32 |
Exact Molecular Weight | 112.089 | nRing | 2 |
Solubility: LogS | -4.085 | nHRing | 0 |
Solubility: LogP | 1.889 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 7 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 20.4935 |
nHD | 1 | BPOL | 12.0385 |
QED | 0.474 |
Synth | 6.042 |
Natural Product Likeliness | 3.323 |
NR-PPAR-gamma | 0.652 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.973 |
Pgp-sub | 0.125 |
HIA | 0.234 |
CACO-2 | -5.353 |
MDCK | 0.00004 |
BBB | 0.976 |
PPB | 0.685458 |
VDSS | 0.614 |
FU | 0.348399 |
CYP1A2-inh | 0.003 |
CYP1A2-sub | 0.18 |
CYP2c19-inh | 0.015 |
CYP2c19-sub | 0.623 |
CYP2c9-inh | 0.022 |
CYP2c9-sub | 0.037 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.101 |
CYP3a4-inh | 0.254 |
CYP3a4-sub | 0.399 |
CL | 8.884 |
T12 | 0.122 |
hERG | 0.002 |
Ames | 0.053 |
ROA | 0.986 |
SkinSen | 0.017 |
Carcinogencity | 0.833 |
EI | 0.458 |
Respiratory | 0.975 |
NR-Aromatase | 0.642 |
Antiviral | No |
Prediction | 0.954615 |